Andrew Pippas , MD
Medical Oncologist
Biological Therapy/Immunotherapy Chemotherapy Gene Therapy Pain Management Photodynamic Therapy Targeted Therapy
University of Utah School of Medicine
Medical School
Duke University Hospital
Residency
Duke University Hospital
Fellowship
American Board of Internal Medicine
American Board of Internal Medicine - Hematology
American Board of Internal Medicine - Oncology
GA State Medical License Active through 2017
High pathologic complete response in Her2-positive, early-stage breast cancer to a novel nonanthracycline neoadjuvant chemotherapy.
Zelnak, A. B.,Nikolinakos, P.,Srinivasiah, J.,Jonas, W.,Pippas, A.,Liu, Y.,Li, X.,Torres, M.,O'Regan, R. M.; Clin. Breast Cancer. 2014 Jul 30.
See more >>Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidines.
Lenz, H., Van Cutsem, E., Khambata-Ford, S., Mayer, R.J., Gold, P., Stella, P., Mirtsching, B., Cohn, A.L., Pippas, A.W., Azarnia, N., Tsuchihashi, Z., Mauro, D.J., Ro...; J Clin Oncol. 2006 Oct 20.
See more >>A case report of invasive ductal adenocarcinoma identified in a lymphatic channel: a staging controversy.
Jakub, J.W., Drake, F.D., Pippas, A.W., Gardner, M., Fraile, R.J., Giuliano, R., Pendas, S., Reintgen, D.S.; Cancer Control. 2003-09-01.
See more >>